Suppr超能文献

基于熵驱动电路与毛细管电泳联用的酶免标记 miRNA 多重检测

An enzyme-free and label-free multiplex detection of miRNAs by entropy-driven circuit coupled with capillary electrophoresis.

机构信息

State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, No 163, Xianlin Avenue, Nanjing, 210023, PR China.

State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, No 163, Xianlin Avenue, Nanjing, 210023, PR China.

出版信息

Talanta. 2025 Jan 1;281:126850. doi: 10.1016/j.talanta.2024.126850. Epub 2024 Sep 12.

Abstract

MicroRNAs (miRNAs) are currently recognized as important biomarkers for the early diagnosis and prognostic treatment of cancer. Herein, we developed a simple and label-free method for the multiplex detection of miRNAs, based on entropy-driven circuit (EDC) amplification and non-gel sieving capillary electrophoresis-LED induced fluorescence detection (NGCE-LEDIF) platform. In this system, three different lengths of fuel chains were designed to catalyze three EDC, targeting miRNA-21, miRNA-155, and miRNA-10b, respectively. In the presence of target miRNA, the EDC cycle amplification reaction was triggered, generating numerous stable double-strands products (F-DNA/L-DNA). Since the three miRNAs correspond to three different lengths of F-DNA/L-DNA, they can be easily isolated and detected by NGCE. This strategy has good sensitivity, with detection limits of 68 amol, 292.2 amol, and 394 amol for miRNA-21, miRNA-155, and miRNA-10b, respectively. Additionally, this method has good specificity and can effectively distinguish single-base mismatches of miRNA. The recoveries of the three miRNAs in deproteinized healthy human serum ranged from 91.28 % to 108.4 %, with a relative standard deviation (RSD) of less than 7.9 %. This method was further applied to detect cellular miRNAs in human breast cancer (MCF-7) cell extracts, revealing an up-regulation of miRNA-21, miRNA-155, and miRNA-10b in MCF-7 cells. The successful spiked recovery in human serum and RNA extraction from MCF-7 cells underscores the practicality of this method. Therefore, this strategy has broad application prospects in biomedical research.

摘要

微小 RNA(miRNAs)目前被认为是癌症早期诊断和预后治疗的重要生物标志物。在此,我们开发了一种简单且无需标记的 miRNA 多重检测方法,该方法基于熵驱动电路(EDC)扩增和非凝胶筛分毛细管电泳-LED 诱导荧光检测(NGCE-LEDIF)平台。在该系统中,设计了三种不同长度的燃料链,分别用于催化三种 EDC,靶向 miRNA-21、miRNA-155 和 miRNA-10b。在存在靶 miRNA 的情况下,触发 EDC 循环扩增反应,生成大量稳定的双链产物(F-DNA/L-DNA)。由于这三种 miRNA 对应于三种不同长度的 F-DNA/L-DNA,因此可以通过 NGCE 轻松分离和检测。该策略具有良好的灵敏度,对 miRNA-21、miRNA-155 和 miRNA-10b 的检测限分别为 68 amol、292.2 amol 和 394 amol。此外,该方法具有良好的特异性,可以有效区分 miRNA 的单碱基错配。在去蛋白健康人血清中,三种 miRNA 的回收率在 91.28%至 108.4%之间,相对标准偏差(RSD)小于 7.9%。该方法进一步用于检测人乳腺癌(MCF-7)细胞提取物中的细胞 miRNA,结果显示 MCF-7 细胞中 miRNA-21、miRNA-155 和 miRNA-10b 的表达上调。在人血清和 MCF-7 细胞 RNA 提取中成功添加恢复凸显了该方法的实用性。因此,该策略在生物医学研究中具有广阔的应用前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验